Article
Impacts of florfenicol on the microbiota landscape and resistome as revealed by metagenomic analysis
1 Dec 2019
Abstract excerpt
BACKGROUND: Drug-resistant fish pathogens can cause significant economic loss to fish farmers. Since 2012, florfenicol has become an approved drug for treating both septicemia and columnaris diseases in freshwater fish. Due to the limited drug options available for aquaculture, the impact of the therapeutical florfenicol treatment on the microbiota landscape as well as the resistome present in the aquaculture...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
